Solid-phase synthesis of cyclic RGD-furanoid sugar amino acid peptides as integrin inhibitors

Bioorg Med Chem Lett. 2003 Feb 10;13(3):331-4. doi: 10.1016/s0960-894x(02)01022-3.

Abstract

The solid-phase synthesis of cyclic RGD peptides containing either one or two furanoid sugar amino acids (SAAs) is reported. Using a cyclization-cleavage approach five peptides were successfully assembled and consecutively tested on their ability to bind to the integrin receptors alpha(v)beta(3) and alpha(IIb)beta(3). The cyclic tetrapeptide c[RGD-SAA] (1) showed the most promising activity in an inhibition assay with an IC(50) of 1.49 microM for the alpha(v)beta(3) receptor and 384 nM for the alpha(IIb)beta(3) receptor.

MeSH terms

  • Binding, Competitive / drug effects
  • Blood Coagulation / drug effects
  • Blood Platelets / chemistry
  • Chromatography, High Pressure Liquid
  • Cyclization
  • Humans
  • Indicators and Reagents
  • Integrin alphaVbeta3 / antagonists & inhibitors
  • Integrin alphaVbeta3 / blood
  • Integrins / antagonists & inhibitors*
  • Oligopeptides / chemical synthesis*
  • Platelet Aggregation / drug effects
  • Platelet Membrane Glycoprotein IIb / blood
  • Platelet Membrane Glycoprotein IIb / drug effects
  • Sugar Acids / chemistry*

Substances

  • Indicators and Reagents
  • Integrin alphaVbeta3
  • Integrins
  • Oligopeptides
  • Platelet Membrane Glycoprotein IIb
  • Sugar Acids
  • arginyl-glycyl-aspartic acid